Company intelligence / Profile preview

Signicent

Ownership: Private
Development stage: Other

Overview

Signicent is an ISO-certified global KPO specializing in intellectual property research, market/business/technology analysis, patent analytics and landscape studies. It serves over 400 clients worldwide—including Fortune 100 companies—across industries such as biotech/pharma/life sciences. The company does not develop its own drugs or therapies but provides critical R&D support to organizations innovating in these fields.

Modalities: BiologicSmall moleculeVaccine
Industry: Consulting

Partnerships

No major pharmaceutical or biotech partnerships disclosed; works with a wide range of clients including startups to Fortune Global companies under NDA/confidentiality agreements

Beyond the preview

Go deeper on Signicent.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signicent.

Explore the full profile